// App-Quantinova.ai

BSH19‐EP‐066 : Use of extended half‐life Factor VIII and IX concentrates in haemophilia: a clinical audit

Researchers

Presenter

  • P. Elder

Principal Investigators

  • B. Bailiff

  • K. Marshall

Medical Centers

  • Foundation Programme

  • Department of Gastroenterology, University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • Recombinant Factor VIII

  • Alprolix Intravenous

  • Antihemophilic factor recombinant

  • BeneFIX

  • Advate

  • Elocta

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved